ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Bone Marrow Resident Long-Lived Plasma Cells as Source of Chronic Donor-Specific Antibodies

M. Muckenhuber, S. Pichler, A. M. Weijler, T. Wekerle

Dept. of General Surgery, Div. of Transplantation, Medical University of Vienna, Vienna, Austria

Meeting: 2022 American Transplant Congress

Abstract number: 1221

Keywords: B cells, Bone marrow, HLA antibodies

Topic: Basic Science » Basic Science » 04 - B-cell / Antibody /Autoimmunity

Session Information

Session Name: B-cell / Antibody /Autoimmunity

Session Type: Poster Abstract

Date: Monday, June 6, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: The importance of bone marrow resident plasma cells for long-lasting humoral immunity has been highlighted in several models for vaccination and infectious diseases. To which extent this cell population is also responsible for upholding a sustained humoral response against (donor)-HLA antigens in the transplant setting remains unclear. We therefore sought to identify and characterize DSA-secreting plasma cells to provide insight into their underlying biology.

*Methods: C57BL/6 were grafted with a fully mismatched balb/c cardiac allograft without any immunosuppressive treatment. Serum DSA were assessed regularly via flow crossmatch. Spleen and bone marrow cells of each cardiac allograft recipient were harvested 20 weeks post transplantation und cultured separately for 48h. DSA within the cell culture supernatants were measured via flow crossmatch. Splenic and bone marrow plasma cells were quantified and characterized using flow cytometry in transplant recipients and age-matched naïve individuals. To directly identify DSA-secreting plasma cells, fluorophore conjugated donor MHC-tetramers were used for intracellular staining of fixed and permeabilized plasma cells.

*Results: Fully mismatched balb/c heart allografts were rapidly rejected within 12 days in untreated BL6 recipients and elicited a substantial humoral allo-immune response. Bone marrow and spleen cells harvested from each individual cardiac allograft recipient 20 weeks post transplantation were cultured separately. A flow crossmatch of the supernatant demonstrated that this chronic DSA response was almost exclusively carried by the bone marrow rather than the spleen (mean in-vitro IgG DSA MFI; bone marrow: 441 vs. spleen: 59; p=0.0002). Within their bone marrow, transplant recipients carried a substantially greater proportion and absolute number of long-lived plasma cells (LLPC; B220- CD138+ TACI+ CD19-) (% LLPC within all plasma cells; naïve (n=7): 15.26 +/- 4.88% vs. HTX recipients (n=12): 33.60 +/- 5.04%; p=0.002) (LLPC x106; naïve (n=7): 0.18 +/- 0.07 vs. HTX recipients (n=12): 0.46 +/- 0.04; p=0.0004) [Fig. 1A]. In-situ staining of DSA within permeabilized plasma cells using fluorophore conjugated donor-MHC tetramers demonstrated that a substantial proportion of bone-marrow LLPCs secretes donor-MHC specific IgG [Fig. 1B].

*Conclusions: Bone marrow resident long-lived plasma cells represent a crucial source of late donor-specific antibodies.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Muckenhuber M, Pichler S, Weijler AM, Wekerle T. Bone Marrow Resident Long-Lived Plasma Cells as Source of Chronic Donor-Specific Antibodies [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/bone-marrow-resident-long-lived-plasma-cells-as-source-of-chronic-donor-specific-antibodies/. Accessed May 28, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences